• SENSEX 78,094.64
    166.49 (+0.21%)
  • BANKNIFTY 57,264.85
    117.35 (+0.21%)
  • Bajaj Finance
    1,151.20 1,151.20(%)
  • Torrent Pharma.
    5,139.30 5,139.30(%)
  • Netweb Technol.
    4,597.95 5,241.65(%)
  • TVS Motor Co.
    4,320.00 4,320.00(%)
  • Rossell Techsys
    979.95 1,111.00(%)
  • Indo-MIM
    815.90 815.90(%)
  • Kaynes Tech
    3,860.55 7,705.00(%)
  • Hero Motocorp
    5,397.80 6,390.00(%)
  • 63 Moons Tech.
    949.65 1,029.35(%)
  • Adani Ports
    1,707.00 1,891.80(%)
  • Shadowfax Technologies
    253.35 253.35(%)
  • Kalyan Jewellers
    610.15 327.15(%)
  • M & M
    3,456.00 3,840.00(%)
  • Tata Motors
    440.40 508.95(%)
  • HFCL
    194.30 229.40(%)
  • Hyundai Motor I
    2,208.90 2,889.65(%)
  • Swiggy
    280.00 235.85(%)
  • TBO Tek
    1,565.80 1,764.00(%)
  • Reliance Industries
    1,309.30 1,611.20(%)
  • Eicher Motors
    7,795.00 5,390.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Fredun Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5269.0
  • ISIN : INE194R01017
987.00 52 (5.54%)
  • As on 01 Aug 2026 (EOD)

  • Today’s Low

    955.00

  • Today’s High

    999.00

  • Open

    970.00

  • Perv Close

    935.15

  • 52W Low

    324.00

  • 52W High

    999.00

Key Indicators

  • P/E(TTM)

    49.15

  • Mar.Cap (₹Cr.)

    1,632.31

  • Div & Yield %

    0.02

  • Book Value(₹)

    163.14

  • Debt-Equity Ratio

    5.54

  • AGM Date

    31-Jul-2026

  • EPS

    20.08

  • P/E Ratio

    49.15

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    1,632.31

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.54

  • BV (₹)

    163.10

  • Sales( ₹ in Cr.)

    635.47

  • NP (in Cr.)

    33.21

  • NP Var(%)

    60.0

  • Div%

    7.0

  • CPS (₹)

    24.90

  • EPS (₹)

    20.10

  • Traded Value (₹ in Lakhs)

    1,632.31

  • 52 Week High

    999.00

  • 52 Week Low

    324.00

  • Price BSE

    987.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    1,632.31

  • P/C Ratio

    39.70

  • P/E Ratio

    49.20

  • Price Vs.BV

    20.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 635.47 453.82 348.16 274.68 224.46 133.89
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 635.47 453.82 348.16 274.68 224.46 133.89
Other Income 3.66 2.45 0.92 1.82 1.63 1.40
Stock Adjustments 31.69 -6.05 22.44 37.72 0.01 -1.17
Total Income 670.82 450.22 371.52 314.22 226.10 134.12
EXPENDITURE :            
Raw Materials 480.76 321.89 282.42 245.57 176.45 100.60
Power and Fuel Cost 5.35 4.79 4.03 3.17 3.68 3.32
Employee Cost 32.94 22.23 12.50 11.54 10.66 8.66
Other Manufacturing Expenses 17.66 17.17 11.68 8.08 6.59 3.87
Selling and Administration Expenses 36.72 26.42 20.77 14.55 12.76 7.80
Miscellaneous Expenses 2.59 2.63 1.22 1.71 0.46 0.28
Employee Benefit Expenses 32.94 22.23 12.50 11.54 10.66 8.66
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 576.02 395.12 332.61 284.62 210.60 124.54
Operating Profit 94.80 55.10 38.90 29.60 15.50 9.58
Interest 39.30 22.38 13.65 9.28 4.74 4.37
Gross Profit 55.50 32.72 25.25 20.32 10.76 5.21
Depreciation 7.91 4.45 3.80 2.81 2.16 2.00
Profit Before Tax 47.59 28.27 21.45 17.51 8.60 3.21
Current Tax 12.31 7.12 5.54 4.29 2.21 0.76
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.06 0.35 0.29 2.41 0.05 0.44
Reported Net Profit 33.21 20.81 15.62 10.81 6.34 2.01
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 33.21 20.81 15.62 10.81 6.34 2.01
Adjustment below Net Profit 0.17 -20.81 -0.07 0.05 0.02 0.00
P & L Balance brought forward 63.91 63.91 28.55 18.00 11.93 10.18
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.33 0.00 0.33 0.31 0.28 0.27
P & L Balance carried down 96.95 63.91 43.77 28.55 18.00 11.93
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 7.00 7.00 7.00 7.00 7.00 7.00
Dividend Per Share(Rs) 0.70 0.70 0.70 0.70 0.70 0.70
Earnings Per Share-Unit Curr 60.68 44.07 33.25 23.84 14.29 5.05
Earnings Per Share(Adj)-Unit Curr 20.23 14.69 11.08 7.95 4.76 1.68
Book Value 483.87 299.47 255.15 194.27 153.07 107.96
Book Value(Adj)-Unit Curr 161.29 99.82 85.05 64.76 51.02 35.99

Shareholding Pattern

  • Promoter Group

    44.57%

  • Public Share Holding

    55.43%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 7,371,159 44.57 7,371,159 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,371,159 44.57 7,371,159 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 225,000 1.36 225,000 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 175,980 1.06 175,980 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 260,592 1.58 260,592 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 661,572 4.00 661,572 9
2] Non Institution
Bodies Corporate 623,721 3.77 581,421 102
Clearing Members 2,853 0.02 2,853 5
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 371,886 2.25 371,886 290
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 213,078 1.29 213,078 189
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,634,554 21.98 3,634,554 53
Individuals holding nominal share capital up to Rs. 1 lakh 3,579,249 21.64 3,387,639 8,926
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,505,339 51.43 8,262,129 9,586
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,538,070 100.00 16,294,860 9,598

Company Background

Fredun Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Fredun Pharmaceuticals Ltd
  • BSE Code : 5269.0
  • ISIN : INE194R01017

  • Incorporation Year

    1987

  • Registered Office

    26 Manoj Industrial Premises
    G D Ambedkar Marg Wadala, Mumbai,
    Maharashtra-400031

  • Telephone

    91-22-40318111

  • FAX

  • Chairman

    Daulat N Medhora

  • Managing Director

    Fredun N Medhora

  • Company Secretary

    Vaishnavi Rajkamal Sahu

  • Auditor

    R.H. Nisar & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Fredun Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Fredun Pharma 987.00 639.12 635.47 49.15 21.28
Abbott India 27,784.15 7,217.19 6,929.05 38.04 43.78
Astrazeneca Phar 8,103.65 2,304.07 2,275.58 108.03 27.86
P & G Health Ltd 6,597.45 944.52 934.17 33.50 71.75
Glaxosmi. Pharma 2,653.45 3,932.76 3,790.20 44.42 58.17
Cipla 1,472.95 20,102.60 18,979.95 38.71 13.88
Amrutanjan Healt 515.00 469.50 451.82 25.71 21.89
Fermenta Biotec. 501.25 474.15 450.25 22.95 18.77
Bliss GVS Pharma 467.40 773.53 729.81 51.25 12.51
Guj. Themis Bio. 358.85 152.47 150.80 83.84 27.21
Ambalal Sarabhai 34.87 19.52 3.94 24.38 6.77